Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kyrgidis

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
British Journal of Cancer|August 7, 2008
Regular dental check-ups could be of benefit for patients receiving intravenous bisphosphonates. Regarding 'risks and benefits of bisphosphonates'A Kyrgidis, S Triaridis
Hippokratia|April 14, 2011
Peer review and journal impact factor: the two pillars of contemporary medical publishingS Triaridis, A Kyrgidis
Hippokratia|April 14, 2011
Methods and Biostatistics: a concise guide for peer reviewersA Kyrgidis, S Triaridis
British Dental Journal|June 13, 2009
A safe modalityA Kyrgidis, K Vahtsevanos
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 23, 2010
Denosumab-related osteonecrosis of the jawsA Kyrgidis, K A Toulis
International Journal of Dental Hygiene|June 5, 2010
The role of dental hygienist in the prevention of osteonecrosis of the jaw in patients wearing denturesA Kyrgidis, Z Teleioudis, K Vahtsevanos
Hippokratia|February 26, 2009
New evidence on bisphosphonate related osteonecrosis of the jaws suggests dental referral prior to commencement of treatmentA Kyrgidis, St Triaridis, K Vahtsevanos
Journal of the European Academy of Dermatology and Venereology : JEADV|March 13, 2012
Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trialsT Tzellos, A Kyrgidis, C C Zouboulis
International Angiology : a Journal of the International Union of Angiology|December 22, 2010
Preoperative withdrawal of antiplatelet treatment in lower limb vascular patients prior to surgical management under epidural or spinal anaesthesia: an evidence based approach and systematic reviewG Kotsovolis, G Komninos, A Kyrgidis, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 7, 2013
Association of anti-IL-12/23 biologic agents ustekinumab and briakinumab with major adverse cardiovascular eventsT Tzellos, A Kyrgidis, A Trigoni, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|August 7, 2008
Regular dental check-ups could be of benefit for patients receiving intravenous bisphosphonates. Regarding 'risks and benefits of bisphosphonates'A Kyrgidis, S Triaridis
Hippokratia|April 14, 2011
Peer review and journal impact factor: the two pillars of contemporary medical publishingS Triaridis, A Kyrgidis
Hippokratia|April 14, 2011
Methods and Biostatistics: a concise guide for peer reviewersA Kyrgidis, S Triaridis
British Dental Journal|June 13, 2009
A safe modalityA Kyrgidis, K Vahtsevanos
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 23, 2010
Denosumab-related osteonecrosis of the jawsA Kyrgidis, K A Toulis
International Journal of Dental Hygiene|June 5, 2010
The role of dental hygienist in the prevention of osteonecrosis of the jaw in patients wearing denturesA Kyrgidis, Z Teleioudis, K Vahtsevanos
Hippokratia|February 26, 2009
New evidence on bisphosphonate related osteonecrosis of the jaws suggests dental referral prior to commencement of treatmentA Kyrgidis, St Triaridis, K Vahtsevanos
Journal of the European Academy of Dermatology and Venereology : JEADV|March 13, 2012
Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trialsT Tzellos, A Kyrgidis, C C Zouboulis
International Angiology : a Journal of the International Union of Angiology|December 22, 2010
Preoperative withdrawal of antiplatelet treatment in lower limb vascular patients prior to surgical management under epidural or spinal anaesthesia: an evidence based approach and systematic reviewG Kotsovolis, G Komninos, A Kyrgidis, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 7, 2013
Association of anti-IL-12/23 biologic agents ustekinumab and briakinumab with major adverse cardiovascular eventsT Tzellos, A Kyrgidis, A Trigoni, et al.
Pageof 6